Earlier availability of COVID-19 vaccines in 2024 compared to 2023 may have contributed to higher vaccination rates among healthcare workers, according to an April 2 CDC report.
Between the 2023-24 and 2024-25 respiratory seasons, the percentage of healthcare workers who reported receiving a COVID-19 vaccine increased from 31.3% to 40.2%, according to the CDC’s latest Morbidity and Mortality Weekly Report.
The report also included flu vaccination rates among healthcare professionals, showing little change year over year: 76.3% during 2024-25 and 75.4% during 2023-24. The CDC’s vaccine advisory panel recommends all healthcare workers receive an annual flu vaccine, and in 2024, the panel extended the guidance to include COVID-19 vaccination.
In addition to the new recommendation, the 2024 COVID-19 vaccine became available in August — about one month earlier than it did in 2023, according to the report.
“Early availability of the vaccine might have given HCP [healthcare personnel] more exposure to workplace vaccination policies and campaigns and permitted them more time to receive a COVID-19 vaccine,” the researchers concluded. “Aligning COVID-19 vaccine delivery, communication and promotion with those for influenza vaccine has the potential to increase coverage with both vaccines during peak respiratory virus season.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
